11 /100
LOW RISK
Score updated Jul 13, 2026

LMAT — LeMaitre Vascular, Inc. Dilution Risk Tracker

Track LMAT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LMAT — Get alerts when the score changes →

As of July 13, 2026, LeMaitre Vascular, Inc. (LMAT) has a DilutionWatch DilutionScore of 11/100, rated LOW dilution risk. LeMaitre Vascular, Inc. has a market capitalization of $2.16B, 22.85M shares outstanding, 340 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for LMAT.
🔔 Track LMAT — Get forecast alerts →

💹 Market Data

Market Cap$2.16B
Shares Outstanding22.85M
Float21.27M
Cash$26.85M
Debt$189.82M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 12.9% shares (2026Q1 vs prior)
340 institutional holders · 24.81M shares
#1 BlackRock, Inc. 3.14M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 1.82M shares
#3 Conestoga Capital Advisors, LLC 1.48M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.36M
Days to Cover3.3
% of Float6.4%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

4 INSIDER TRANSACTION Mar 30, 2026
4 INSIDER TRANSACTION Mar 30, 2026
4 INSIDER TRANSACTION Mar 30, 2026
4 INSIDER TRANSACTION Mar 30, 2026
4 INSIDER TRANSACTION Mar 30, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for LMAT Shareholders

LeMaitre Vascular, Inc. (LMAT) has a DilutionScore of 11/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for LMAT shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for LMAT in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for LMAT alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track LMAT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LMAT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for LMAT
📊 LMAT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 LMAT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.